{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T21:14:31Z","timestamp":1648934071059},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,9,28]],"date-time":"2016-09-28T00:00:00Z","timestamp":1475020800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00108-016-0140-9","type":"journal-article","created":{"date-parts":[[2016,9,28]],"date-time":"2016-09-28T06:29:18Z","timestamp":1475044158000},"page":"1060-1068","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management der axialen Spondyloarthritis"],"prefix":"10.1007","volume":"57","author":[{"given":"U.","family":"Kiltz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,28]]},"reference":[{"issue":"9783","key":"140_CR1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377(9783):2127\u20132137","journal-title":"Lancet"},{"issue":"6","key":"140_CR2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M et\u00a0al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis 68(6):777\u2013783","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"140_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M et\u00a0al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25\u201331","journal-title":"Ann. Rheum. Dis."},{"key":"140_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.38291","volume":"66","author":"JA Smith","year":"2014","unstructured":"Smith JA, Colbert RA (2014) The IL-23\/IL-17 axis in spondyloarthritis pathogenesis: Th17 and beyond. Arthritis Rheum 66:231\u2013241","journal-title":"Arthritis Rheum."},{"issue":"8","key":"140_CR5","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1136\/ard.2008.092494","volume":"68","author":"M Neidhart","year":"2009","unstructured":"Neidhart M et al (2009) Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis. Ann Rheum Dis 68(8):1334\u20131339","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 2","key":"140_CR6","first-page":"44","volume":"75","author":"D Heijde Van der","year":"2016","unstructured":"Van der Heijde D et al (2016) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 75(Suppl 2):44","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 2","key":"140_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00393-014-1425-9","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Braun J (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: Editorial. Z Rheumatol 73(Suppl 2):20\u201322","journal-title":"Z Rheumatol"},{"issue":"2","key":"140_CR8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.21619","volume":"54","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M et\u00a0al (2006) Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 54(2):569\u2013578","journal-title":"Arthritis Rheum."},{"issue":"4","key":"140_CR9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/rheumatology\/keu388","volume":"54","author":"I Essers","year":"2015","unstructured":"Essers I et al (2015) Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS. Rheumatology (Oxford) 54(4):633\u2013640","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"140_CR10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"E Feldtkeller","year":"2003","unstructured":"Feldtkeller E et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61\u201366","journal-title":"Rheumatol. Int."},{"issue":"6","key":"140_CR11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/annrheumdis-2013-204953","volume":"74","author":"S Ramiro","year":"2015","unstructured":"Ramiro S et\u00a0al (2015) Reference intervals of spinal mobility measures in normal individuals: the MOBILITY study. Ann Rheum Dis 74(6):1218\u20131224","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 2","key":"140_CR12","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J et\u00a0al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: A guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1\u2013ii44","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"140_CR13","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D et al (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64(5):1388\u20131398","journal-title":"Arthritis Rheum."},{"issue":"1","key":"140_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","volume":"41","author":"J Braun","year":"1998","unstructured":"Braun J et al (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41(1):58\u201367","journal-title":"Arthritis Rheum."},{"issue":"Suppl 2","key":"140_CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00393-014-1442-8","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 8.3 Nonpharmaceutical therapeutic measures. Z Rheumatol 73(Suppl 2):71\u201377","journal-title":"Z Rheumatol"},{"issue":"Suppl 2","key":"140_CR16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00393-014-1443-7","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures. Z Rheumatol 73(Suppl 2):78\u201396","journal-title":"Z Rheumatol"},{"issue":"3","key":"140_CR17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M et\u00a0al (2009) The early disease stage in axial spondylarthritis: Results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 60(3):717\u2013727","journal-title":"Arthritis Rheum."},{"issue":"10","key":"140_CR18","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","volume":"71","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D et al (2012) Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: Results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 71(10):1616\u20131622","journal-title":"Ann. Rheum. Dis."},{"key":"140_CR19","first-page":"CD005468","volume":"4","author":"LJ Maxwell","year":"2015","unstructured":"Maxwell LJ et al (2015) TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev 4:CD005468","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"140_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/annrheumdis-2012-202698","volume":"73","author":"X Baraliakos","year":"2013","unstructured":"Baraliakos X et al (2013) Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis. Ann Rheum Dis 73(4):710\u2013715. doi: 10.1136\/annrheumdis-2012-202698","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"140_CR21","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/rheumatology\/kew033","volume":"55","author":"V Navarro-Compan","year":"2016","unstructured":"Navarro-Compan V et al (2016) Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: A systematic literature review. Rheumatology (Oxford) 55(7):1188\u20131194. doi: 10.1093\/rheumatology\/kew033","journal-title":"Rheumatology (Oxford)"},{"issue":"26","key":"140_CR22","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten D et al (2015) Secukinumab, an Interleukin-17A inhibitor, in Ankylosing Spondylitis. N Engl J Med 373(26):2534\u20132548","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 2","key":"140_CR23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00393-014-1444-6","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 8.6 Invasive therapy. Z Rheumatol 73(Suppl 2):97\u2013100","journal-title":"Z Rheumatol"},{"issue":"1","key":"140_CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/ard.2006.053918","volume":"66","author":"L Heuft-Dorenbosch","year":"2007","unstructured":"Heuft-Dorenbosch L et al (2007) Performance of various criteria sets in patients with inflammatory back pain of short duration; The Maastricht early spondyloarthritis clinic. Ann Rheum Dis 66(1):92\u201398","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"140_CR25","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"A Wanders","year":"2005","unstructured":"Wanders A et\u00a0al (2005) Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial. Arthritis Rheum 52(6):1756\u20131765","journal-title":"Arthritis Rheum."},{"issue":"8","key":"140_CR26","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1136\/annrheumdis-2015-207897","volume":"75","author":"J Sieper","year":"2015","unstructured":"Sieper J et al (2015) Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: Results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis 75(8):1438\u20131443. doi: 10.1136\/annrheumdis-2015-207897","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"140_CR27","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23471","volume":"58","author":"D Heijde van der","year":"2008","unstructured":"van der Heijde D et\u00a0al (2008) Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 58(5):1324\u20131331","journal-title":"Arthritis Rheum."},{"issue":"4","key":"140_CR28","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.20990","volume":"52","author":"M Rudwaleit","year":"2005","unstructured":"Rudwaleit M et\u00a0al (2005) The challenge of diagnosis and classification in early ankylosing spondylitis. Do we need new criteria? Arthritis Rheum 52(4):1000\u20131008","journal-title":"Arthritis Rheum."}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-016-0140-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T02:18:28Z","timestamp":1568427508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-016-0140-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,28]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1007\/s00108-016-0140-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,28]]}}}